|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
EBOOKCENTRAL_ocn575079240 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
100326s2003 ii a o 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d IDEBK
|d OCLCQ
|d YDXCP
|d OCLCQ
|d OCLCF
|d OCLCQ
|d EBLCP
|d OCLCQ
|d ZCU
|d MERUC
|d OCLCQ
|d ICG
|d OCLCQ
|d DKC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCL
|
| 019 |
|
|
|a 923652145
|
| 020 |
|
|
|a 9788122429152
|q (electronic bk.)
|
| 020 |
|
|
|a 8122429157
|q (electronic bk.)
|
| 029 |
1 |
|
|a DEBBG
|b BV044087056
|
| 035 |
|
|
|a (OCoLC)575079240
|z (OCoLC)923652145
|
| 050 |
|
4 |
|a RS160
|b .K37 2003eb
|
| 072 |
|
7 |
|a HEA
|x 011000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615/.321
|2 22
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Kar, Ashutosh.
|
| 245 |
1 |
0 |
|a Pharmacognosy and pharmacobiotechnology /
|c Ashutosh Kar.
|
| 250 |
|
|
|a Rev. -expanded 2nd ed.
|
| 260 |
|
|
|a New Delhi :
|b New Age International (P) Ltd.,
|c 2003.
|
| 300 |
|
|
|a 1 online resource (xvii, 879 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Cover -- Preface to the Second Edition -- Preface to the First Edition -- Contents -- Chapter 1. Introduction -- 1.1 Pharmacognosy-A Brief History -- 1.2 Importance of Natural Drug Substances -- 1.2.1 Serve as Extremely Useful Natural Drugs -- 1.2.2 Provide Basic Compounds Affording Less Toxic and More Effective Drug Molecules -- 1.2.3 Exploration of Biological�Active�Prototypes towards Newer and Better Synthetic Drugs -- 1.2.4 Modificaton of Inactive Natural Products by Suitable Biological/Chemical Means into Potent Drugs
|
| 505 |
8 |
|
|a 1.3 Natural Drugs Substances: Cultivation and Production 1.3.1 Plant Products -- 1.3.2 Cell-Culture Techniques -- 1.3.3 Microbial Metabolites -- 1.3.4 Animal Derivatives -- 1.4 Phytochemistry -- 1.4.1 Constituents -- Chapter 2. Pharmacobiotechnology -- 2.1 Introduction -- 2.2 Theory -- 2.2.1 Mutation, Crossing-over and Recombinant of Meiosis -- 2.2.2 Third Revolution in Modern Medicine -- 2.2.3 Genetic Code -- 2.2.4 Specific Sets of Genes in Each Individual Organ -- 2.2.5 Reverse Transcriptase (RT) -- 2.2.6 3D-Proteins
|
| 505 |
8 |
|
|a 2.2.7 From Nervous System to Immune System2.2.8 Body�s Defence Mechanism -- 2.2.9 PCR�in Forensic & Research -- 2.2.10 DNA�in Metabolic Pathways -- 2.2.11 Recombinant Vaccination Vector -- 2.2.12 OKT3�Monoclonal Antibody -- 2.3 Important Means in Biotechnology -- 2.3.1 Recombinant DNA (rDNA) -- 2.3.2 Restriction Enzymes -- 2.3.3 DNA�Ligase -- 2.3.4 Cloning Vector -- 2.3.5 Hybridization Probes -- 2.3.6 Cloning Process -- 2.4 Recombinant Proteins -- 2.4.1 Bacterial Systems -- 2.4.2 Glycosylation
|
| 505 |
8 |
|
|a 2.4.3 Mammalian Tissue Culture Expression Systems2.5 Biotechnology Vs Modern Pharmacy Practice -- 2.5.1 Human Proteins as Drugs -- 2.5.2 New Drug Classes -- 2.5.3 Vaccines -- 2.5.4 New Immunodiagnostic Agents -- 2.5.5 DNA Probes and RFLP Analysis -- 2.5.6 Enzyme Linked Immunosorbant Assay (ELISA) -- 2.6 Biotechnology Based Pharmaceuticlas for the Millennium -- 2.6.1 Genetically Engineered Vaccine -- 2.6.2 Gene Splicing and DNA Recombinant Procedures -- 2.6.3 Antibodies in Biotechnology -- 2.6.4 Gene Therapy -- 2.6.5 3D Picture of the �Lock� and �Keys�
|
| 505 |
8 |
|
|a 2.7 Biotechnology and Modern Drug Discovery 2.7.1 Approved Medicines -- 2.7.2 Medicines Under Development -- 2.7.3 Human Clone -- 2.8 Biotechnology: Some Thought Provoking Newer Ideas -- 2.8.1 Potato Vaccine -- 2.8.2 Functional Food Revolution -- Chapter 3. Carbobhydrates -- 3.1 Introductioin -- 3.2 Classification -- 3.2.1 Homoglycans -- 3.2.2 Heteroglycans -- 3.3 Carbohydrate Biogenesis -- Chapter 4. Glycosides -- 4.1 Introduction -- 4.1.1 O-Glycosides -- 4.1.2 S-Glycosides -- 4.1.3 N-Glycosides -- 4.1.4 C-Glycosides -- 4.2 Classification
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Pharmacognosy.
|
| 650 |
|
0 |
|a Pharmaceutical biotechnology.
|
| 650 |
|
2 |
|a Pharmacognosy
|
| 650 |
|
6 |
|a Pharmacognosie.
|
| 650 |
|
6 |
|a Biotechnologie pharmaceutique.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Herbal Medications.
|2 bisacsh
|
| 650 |
|
7 |
|a Pharmaceutical biotechnology
|2 fast
|
| 650 |
|
7 |
|a Pharmacognosy
|2 fast
|
| 758 |
|
|
|i has work:
|a Pharmacognosy and pharmacobiotechnology (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCG9xGwH4vpdqrpx4j7JQ7b
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Kar, Ashutosh.
|t Pharmacognosy and pharmacobiotechnology.
|b Rev.-expanded 2nd ed.
|d New Delhi : New Age International (P) Ltd., 2003
|z 9788122419603
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3017377
|z Texto completo
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3017377
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 307424
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 3291149
|
| 994 |
|
|
|a 92
|b IZTAP
|
